Increased susceptibility of Cryptococcus neoformans to amphotericin B in the presence of steroids.
D000666:Amphotericin B / Q000494:pharmacology*; D003453:Cryptococcosis / Q000134:cerebrospinal fluid; D003454:Cryptococcus / Q000187:drug effects*; D003455:Cryptococcus neoformans / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D004054:Diethylstilbestrol / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D006801:Humans; D008581:Meningitis / Q000134:cerebrospinal fluid; D009641:Norethynodrel / Q000494:pharmacology; D011278:Pregnanes / Q000494:pharmacology*; D011374:Progesterone / Q000494:pharmacology; D013739:Testosterone / Q000494:pharmacology*; D013997:Time Factors
D004967:Estrogens; D011278:Pregnanes; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D004054:Diethylstilbestrol; D000666:Amphotericin B; D009641:Norethynodrel